Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Malignant Mesothelioma |
| Start Date: | May 1, 2010 |
| Phase: | Phase I|Phase II |
| Status: | Recruiting |
| NCT ID: | NCT01064648 |
| Study Type: | Interventional |
| Intervention: | Drug: cediranib maleate|Drug: cisplatin|Drug: pemetrexed disodium|Other: placebo |
| Study Design: | Allocation: Randomized|Control: Placebo Control|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Southwest Oncology Group|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 116 |
| Funded By: | Other|NIH |
| First Received: | February 5, 2010 |
| End Date: | |
| Last Updated: | October 14, 2010 |
| Last Verified: | October 1, 2010 |